State Street Corp Opiant Pharmaceuticals, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $21.1 $0 - $339,393	-16,085 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$9.38 - $20.29 $26,264 - $56,812	2,800 Added 21.08%	16,085 $326,000
Q1 2022 May 16, 2022	BUY	$19.54 - $33.59 $25,108 - $43,163	1,285 Added 10.71%	13,285 $285,000
Q4 2021 Feb 14, 2022	BUY	$22.51 - $36.79 $270,120 - $441,480	12,000 New	12,000 $404,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.